_id
691099d0ccc777a4e85d5c9c
Ticker
EVLO
Name
Evelo Biosciences Inc
Exchange
PINK
Address
620 Memorial Drive, Cambridge, MA, United States, 02139
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.evelobio.com
Description
Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Last Close
0.0002
Volume
-
Current Price
0.0001
Change
-50
Last Updated
2025-11-30T18:26:33.085Z
Image
-
Ipo Date
2018-05-09T00:00:00.000Z
Market Cap
7593
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3
Target Price
10
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2023-09-30
Revenue
0
Cost Of Revenue
793000
Gross Profit
-793000
Operating Expenses
10390000
Operating Income
-11183000
Interest Expense
1162000
Pretax Income
-12381000
Net Income
-12364000
Eps
-71.1218774380915
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-17000
EBITDA
-11050000
Operating Margin
-
Total Other Income Expense Net
-1198000
Cash
17262000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
18936000
Property Plant Equipment
894000
Total Assets
20627000
Payables
526000
Short Term Debt
33948000
Long Term Debt
-
Total Liabilities
47334000
Equity
-26707000
Depreciation
169000
Change In Working Capital
-3494000
Cash From Operations
-10408000
Capital Expenditures
47000
Cash From Investing
513000
Cash From Financing
19220000
Net Change In Cash
9276000
PE
-
PB
-6.509245890590482e-7
ROE
46.2949788444977
ROA
-59.940854220196826
FCF
-10455000
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
2
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
4.5
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2023-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
793000
Quarters > 0 > income Statement > gross Profit
-793000
Quarters > 0 > income Statement > operating Expenses
10390000
Quarters > 0 > income Statement > operating Income
-11183000
Quarters > 0 > income Statement > interest Expense
1162000
Quarters > 0 > income Statement > pretax Income
-12381000
Quarters > 0 > income Statement > net Income
-12364000
Quarters > 0 > income Statement > eps
-71.1218774380915
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
173842.43
Quarters > 0 > income Statement > income Tax Expense
-17000
Quarters > 0 > income Statement > EBITDA
-11050000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-1198000
Quarters > 0 > balance Sheet > cash
17262000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
18936000
Quarters > 0 > balance Sheet > property Plant Equipment
894000
Quarters > 0 > balance Sheet > total Assets
20627000
Quarters > 0 > balance Sheet > payables
526000
Quarters > 0 > balance Sheet > short Term Debt
33948000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
47334000
Quarters > 0 > balance Sheet > equity
-26707000
Quarters > 0 > cash Flow > net Income
-12364000
Quarters > 0 > cash Flow > depreciation
169000
Quarters > 0 > cash Flow > change In Working Capital
-3494000
Quarters > 0 > cash Flow > cash From Operations
-10408000
Quarters > 0 > cash Flow > capital Expenditures
47000
Quarters > 0 > cash Flow > cash From Investing
513000
Quarters > 0 > cash Flow > cash From Financing
19220000
Quarters > 0 > cash Flow > net Change In Cash
9276000
Quarters > 0 > ratios > PE
-71.1218774380915
Quarters > 0 > ratios > PB
-6.509245890590482e-7
Quarters > 0 > ratios > ROE
46.2949788444977
Quarters > 0 > ratios > ROA
-59.940854220196826
Quarters > 0 > ratios > FCF
-10455000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2023-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
1616000
Quarters > 1 > income Statement > gross Profit
-1616000
Quarters > 1 > income Statement > operating Expenses
17958000
Quarters > 1 > income Statement > operating Income
-19574000
Quarters > 1 > income Statement > interest Expense
1369000
Quarters > 1 > income Statement > pretax Income
-20870000
Quarters > 1 > income Statement > net Income
-21103000
Quarters > 1 > income Statement > eps
-3.7827355040997412
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
5578767
Quarters > 1 > income Statement > income Tax Expense
233000
Quarters > 1 > income Statement > EBITDA
-19077000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-1296000
Quarters > 1 > balance Sheet > cash
7622000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
11263000
Quarters > 1 > balance Sheet > property Plant Equipment
8134000
Quarters > 1 > balance Sheet > total Assets
20819000
Quarters > 1 > balance Sheet > payables
3765000
Quarters > 1 > balance Sheet > short Term Debt
46605000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
66945000
Quarters > 1 > balance Sheet > equity
-46126000
Quarters > 1 > cash Flow > net Income
-21103000
Quarters > 1 > cash Flow > depreciation
424000
Quarters > 1 > cash Flow > change In Working Capital
-4021000
Quarters > 1 > cash Flow > cash From Operations
-19827000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-12000
Quarters > 1 > cash Flow > cash From Financing
-199000
Quarters > 1 > cash Flow > net Change In Cash
-19845000
Quarters > 1 > ratios > PE
-3.7827355040997412
Quarters > 1 > ratios > PB
-0.000012094625590773101
Quarters > 1 > ratios > ROE
45.750769631010705
Quarters > 1 > ratios > ROA
-101.36413852730679
Quarters > 1 > ratios > FCF
-19827000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2023-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
24900000
Quarters > 2 > income Statement > operating Income
-24900000
Quarters > 2 > income Statement > interest Expense
1111000
Quarters > 2 > income Statement > pretax Income
-25196000
Quarters > 2 > income Statement > net Income
-25341000
Quarters > 2 > income Statement > eps
-4.569823214510777
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
5545291.1
Quarters > 2 > income Statement > income Tax Expense
145000
Quarters > 2 > income Statement > EBITDA
-23640000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-296000
Quarters > 2 > balance Sheet > cash
27472000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
30081000
Quarters > 2 > balance Sheet > property Plant Equipment
10733000
Quarters > 2 > balance Sheet > total Assets
41970000
Quarters > 2 > balance Sheet > payables
1514000
Quarters > 2 > balance Sheet > short Term Debt
46117000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
69358000
Quarters > 2 > balance Sheet > equity
-27388000
Quarters > 2 > cash Flow > net Income
-25341000
Quarters > 2 > cash Flow > depreciation
445000
Quarters > 2 > cash Flow > change In Working Capital
1455000
Quarters > 2 > cash Flow > cash From Operations
-20276000
Quarters > 2 > cash Flow > capital Expenditures
12000
Quarters > 2 > cash Flow > cash From Investing
-12000
Quarters > 2 > cash Flow > cash From Financing
-199000
Quarters > 2 > cash Flow > net Change In Cash
-20470000
Quarters > 2 > ratios > PE
-4.569823214510777
Quarters > 2 > ratios > PB
-0.000020247156053746166
Quarters > 2 > ratios > ROE
92.52592376223163
Quarters > 2 > ratios > ROA
-60.37884203002144
Quarters > 2 > ratios > FCF
-20288000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2022-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
21087000
Quarters > 3 > income Statement > operating Income
-21087000
Quarters > 3 > income Statement > interest Expense
1837000
Quarters > 3 > income Statement > pretax Income
-22997000
Quarters > 3 > income Statement > net Income
-23541000
Quarters > 3 > income Statement > eps
-4.286443142583185
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
5491966
Quarters > 3 > income Statement > income Tax Expense
544000
Quarters > 3 > income Statement > EBITDA
-20637000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-1910000
Quarters > 3 > balance Sheet > cash
47940000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
51573000
Quarters > 3 > balance Sheet > property Plant Equipment
11710000
Quarters > 3 > balance Sheet > total Assets
64441000
Quarters > 3 > balance Sheet > payables
1764000
Quarters > 3 > balance Sheet > short Term Debt
2259000
Quarters > 3 > balance Sheet > long Term Debt
43614000
Quarters > 3 > balance Sheet > total Liabilities
69433000
Quarters > 3 > balance Sheet > equity
-4992000
Quarters > 3 > cash Flow > net Income
-23541000
Quarters > 3 > cash Flow > depreciation
523000
Quarters > 3 > cash Flow > change In Working Capital
-5726000
Quarters > 3 > cash Flow > cash From Operations
-23190000
Quarters > 3 > cash Flow > capital Expenditures
228000
Quarters > 3 > cash Flow > cash From Investing
-228000
Quarters > 3 > cash Flow > cash From Financing
1739000
Quarters > 3 > cash Flow > net Change In Cash
-21111000
Quarters > 3 > ratios > PE
-4.286443142583185
Quarters > 3 > ratios > PB
-0.00011001534455128206
Quarters > 3 > ratios > ROE
471.5745192307692
Quarters > 3 > ratios > ROA
-36.531090454834654
Quarters > 3 > ratios > FCF
-23418000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
74335000
Annuals > 0 > income Statement > operating Income
-74335000
Annuals > 0 > income Statement > interest Expense
5479000
Annuals > 0 > income Statement > pretax Income
-81444000
Annuals > 0 > income Statement > net Income
-82349000
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-1630000
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
-
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
-
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > cash Flow > net Income
-82349000
Annuals > 0 > cash Flow > depreciation
1561000
Annuals > 0 > cash Flow > change In Working Capital
-11786000
Annuals > 0 > cash Flow > cash From Operations
-73701000
Annuals > 0 > cash Flow > capital Expenditures
287000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
20760000
Annuals > 0 > cash Flow > net Change In Cash
-52150000
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
-73988000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
37
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
108466000
Annuals > 1 > income Statement > operating Income
-108466000
Annuals > 1 > income Statement > interest Expense
4672000
Annuals > 1 > income Statement > pretax Income
-113597000
Annuals > 1 > income Statement > net Income
-114527000
Annuals > 1 > income Statement > eps
-26.27709860927113
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
4358434
Annuals > 1 > income Statement > income Tax Expense
930000
Annuals > 1 > income Statement > EBITDA
-106345000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-5131000
Annuals > 1 > balance Sheet > cash
47940000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
51573000
Annuals > 1 > balance Sheet > property Plant Equipment
11710000
Annuals > 1 > balance Sheet > total Assets
64441000
Annuals > 1 > balance Sheet > payables
1764000
Annuals > 1 > balance Sheet > short Term Debt
2259000
Annuals > 1 > balance Sheet > long Term Debt
43614000
Annuals > 1 > balance Sheet > total Liabilities
69433000
Annuals > 1 > balance Sheet > equity
-4992000
Annuals > 1 > cash Flow > net Income
-114527000
Annuals > 1 > cash Flow > depreciation
2060000
Annuals > 1 > cash Flow > change In Working Capital
-9666000
Annuals > 1 > cash Flow > cash From Operations
-101235000
Annuals > 1 > cash Flow > capital Expenditures
622000
Annuals > 1 > cash Flow > cash From Investing
-622000
Annuals > 1 > cash Flow > cash From Financing
81655000
Annuals > 1 > cash Flow > net Change In Cash
-20656000
Annuals > 1 > ratios > PE
-26.27709860927113
Annuals > 1 > ratios > PB
-0.00043654186698717946
Annuals > 1 > ratios > ROE
2294.2107371794873
Annuals > 1 > ratios > ROA
-177.72380937601838
Annuals > 1 > ratios > FCF
-101857000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
115396000
Annuals > 2 > income Statement > operating Income
-115396000
Annuals > 2 > income Statement > interest Expense
3612000
Annuals > 2 > income Statement > pretax Income
-121748000
Annuals > 2 > income Statement > net Income
-122176000
Annuals > 2 > income Statement > eps
-46.18171880392312
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
2645549
Annuals > 2 > income Statement > income Tax Expense
428000
Annuals > 2 > income Statement > EBITDA
-115396000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-6352000
Annuals > 2 > balance Sheet > cash
68441000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
71026000
Annuals > 2 > balance Sheet > property Plant Equipment
15532000
Annuals > 2 > balance Sheet > total Assets
87871000
Annuals > 2 > balance Sheet > payables
1601000
Annuals > 2 > balance Sheet > short Term Debt
1951000
Annuals > 2 > balance Sheet > long Term Debt
46557000
Annuals > 2 > balance Sheet > total Liabilities
79204000
Annuals > 2 > balance Sheet > equity
8667000
Annuals > 2 > cash Flow > net Income
-122176000
Annuals > 2 > cash Flow > depreciation
2216000
Annuals > 2 > cash Flow > change In Working Capital
2068000
Annuals > 2 > cash Flow > cash From Operations
-96725000
Annuals > 2 > cash Flow > capital Expenditures
1519000
Annuals > 2 > cash Flow > cash From Investing
-1481000
Annuals > 2 > cash Flow > cash From Financing
97540000
Annuals > 2 > cash Flow > net Change In Cash
-666000
Annuals > 2 > ratios > PE
-46.18171880392312
Annuals > 2 > ratios > PB
0.00015262195684781355
Annuals > 2 > ratios > ROE
-1409.6688588900427
Annuals > 2 > ratios > ROA
-139.04018390595306
Annuals > 2 > ratios > FCF
-98244000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
16
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
91886000
Annuals > 3 > income Statement > operating Income
-91886000
Annuals > 3 > income Statement > interest Expense
2109000
Annuals > 3 > income Statement > pretax Income
-93257000
Annuals > 3 > income Statement > net Income
-93666000
Annuals > 3 > income Statement > eps
-47.450809540213584
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1973960
Annuals > 3 > income Statement > income Tax Expense
409000
Annuals > 3 > income Statement > EBITDA
-89860000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-1371000
Annuals > 3 > balance Sheet > cash
68857000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
70980000
Annuals > 3 > balance Sheet > property Plant Equipment
18235000
Annuals > 3 > balance Sheet > total Assets
90639000
Annuals > 3 > balance Sheet > payables
1442000
Annuals > 3 > balance Sheet > short Term Debt
1674000
Annuals > 3 > balance Sheet > long Term Debt
30048000
Annuals > 3 > balance Sheet > total Liabilities
60154000
Annuals > 3 > balance Sheet > equity
30485000
Annuals > 3 > cash Flow > net Income
-93666000
Annuals > 3 > cash Flow > depreciation
2026000
Annuals > 3 > cash Flow > change In Working Capital
7765000
Annuals > 3 > cash Flow > cash From Operations
-73063000
Annuals > 3 > cash Flow > capital Expenditures
1321000
Annuals > 3 > cash Flow > cash From Investing
-1315000
Annuals > 3 > cash Flow > cash From Financing
65465000
Annuals > 3 > cash Flow > net Change In Cash
-8913000
Annuals > 3 > ratios > PE
-47.450809540213584
Annuals > 3 > ratios > PB
0.00003237592258487781
Annuals > 3 > ratios > ROE
-307.25274725274727
Annuals > 3 > ratios > ROA
-103.33962201701254
Annuals > 3 > ratios > FCF
-74384000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
23
Valuation > metrics > PE
-71.1218774380915
Valuation > metrics > PB
-6.509245890590482e-7
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
46.2949788444977
Profitability > metrics > ROA
-65.29362061681454
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-9.623924268502583
Risk > final Score
-8
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.5492835180135754
Liquidity > metrics > Quick Ratio
0.5492835180135754
Liquidity > final Score
37
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
55
Prev Profitabilities > 2
55
Prev Risks > 0
-27
Prev Risks > 1
-60
Prev Risks > 2
-16
Prev Liquidities > 0
21
Prev Liquidities > 1
42
Prev Liquidities > 2
100
Updated At
2025-12-14T00:27:21.031Z
Earnings History > 0 > period
2023-09-30
Earnings History > 0 > report Date
2023-11-09
Earnings History > 0 > date
2023-09-30
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.7112
Earnings History > 0 > eps Estimate
-0.97
Earnings History > 0 > eps Difference
0.2588
Earnings History > 0 > surprise Percent
26.6804
Earnings History > 1 > period
2023-06-30
Earnings History > 1 > report Date
2023-08-14
Earnings History > 1 > date
2023-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-3.78
Earnings History > 1 > eps Estimate
-3.3
Earnings History > 1 > eps Difference
-0.48
Earnings History > 1 > surprise Percent
-14.5455
Earnings History > 2 > period
2023-03-31
Earnings History > 2 > report Date
2023-05-15
Earnings History > 2 > date
2023-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.23
Earnings History > 2 > eps Estimate
-0.16
Earnings History > 2 > eps Difference
-0.07
Earnings History > 2 > surprise Percent
-43.75
Earnings History > 3 > period
2022-12-31
Earnings History > 3 > report Date
2023-03-16
Earnings History > 3 > date
2022-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.21
Earnings History > 3 > eps Estimate
-0.28
Earnings History > 3 > eps Difference
0.07
Earnings History > 3 > surprise Percent
25
Earnings History > 4 > period
2022-09-30
Earnings History > 4 > report Date
2022-11-14
Earnings History > 4 > date
2022-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.28
Earnings History > 4 > eps Estimate
-0.33
Earnings History > 4 > eps Difference
0.05
Earnings History > 4 > surprise Percent
15.1515
Earnings History > 5 > period
2022-06-30
Earnings History > 5 > report Date
2022-08-11
Earnings History > 5 > date
2022-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.4
Earnings History > 5 > eps Estimate
-0.43
Earnings History > 5 > eps Difference
0.03
Earnings History > 5 > surprise Percent
6.9767
Earnings History > 6 > period
2022-03-31
Earnings History > 6 > report Date
2022-05-12
Earnings History > 6 > date
2022-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.56
Earnings History > 6 > eps Estimate
-0.58
Earnings History > 6 > eps Difference
0.02
Earnings History > 6 > surprise Percent
3.4483
Earnings History > 7 > period
2021-12-31
Earnings History > 7 > report Date
2022-03-24
Earnings History > 7 > date
2021-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.54
Earnings History > 7 > eps Estimate
-0.61
Earnings History > 7 > eps Difference
0.07
Earnings History > 7 > surprise Percent
11.4754
Earnings History > 8 > period
2021-09-30
Earnings History > 8 > report Date
2021-10-28
Earnings History > 8 > date
2021-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.63
Earnings History > 8 > eps Estimate
-0.54
Earnings History > 8 > eps Difference
-0.09
Earnings History > 8 > surprise Percent
-16.6667
Earnings History > 9 > period
2021-06-30
Earnings History > 9 > report Date
2021-07-29
Earnings History > 9 > date
2021-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.53
Earnings History > 9 > eps Estimate
-0.54
Earnings History > 9 > eps Difference
0.01
Earnings History > 9 > surprise Percent
1.8519
Earnings History > 10 > period
2021-03-31
Earnings History > 10 > report Date
2021-04-29
Earnings History > 10 > date
2021-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.55
Earnings History > 10 > eps Estimate
-0.51
Earnings History > 10 > eps Difference
-0.04
Earnings History > 10 > surprise Percent
-7.8431
Earnings History > 11 > period
2020-12-31
Earnings History > 11 > report Date
2021-03-09
Earnings History > 11 > date
2020-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.62
Earnings History > 11 > eps Estimate
-0.53
Earnings History > 11 > eps Difference
-0.09
Earnings History > 11 > surprise Percent
-16.9811
Earnings History > 12 > period
2020-09-30
Earnings History > 12 > report Date
2020-10-29
Earnings History > 12 > date
2020-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.45
Earnings History > 12 > eps Estimate
-0.5
Earnings History > 12 > eps Difference
0.05
Earnings History > 12 > surprise Percent
10
Earnings History > 13 > period
2020-06-30
Earnings History > 13 > report Date
2020-07-30
Earnings History > 13 > date
2020-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.63
Earnings History > 13 > eps Estimate
-0.78
Earnings History > 13 > eps Difference
0.15
Earnings History > 13 > surprise Percent
19.2308
Earnings History > 14 > period
2020-03-31
Earnings History > 14 > report Date
2020-05-11
Earnings History > 14 > date
2020-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.71
Earnings History > 14 > eps Estimate
-0.73
Earnings History > 14 > eps Difference
0.02
Earnings History > 14 > surprise Percent
2.7397
Earnings History > 15 > period
2019-12-31
Earnings History > 15 > report Date
2020-02-13
Earnings History > 15 > date
2019-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.7
Earnings History > 15 > eps Estimate
-0.61
Earnings History > 15 > eps Difference
-0.09
Earnings History > 15 > surprise Percent
-14.7541
Earnings History > 16 > period
2019-09-30
Earnings History > 16 > report Date
2019-11-05
Earnings History > 16 > date
2019-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.67
Earnings History > 16 > eps Estimate
-0.63
Earnings History > 16 > eps Difference
-0.04
Earnings History > 16 > surprise Percent
-6.3492
Earnings History > 17 > period
2019-06-30
Earnings History > 17 > report Date
2019-08-06
Earnings History > 17 > date
2019-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.65
Earnings History > 17 > eps Estimate
-0.62
Earnings History > 17 > eps Difference
-0.03
Earnings History > 17 > surprise Percent
-4.8387
Earnings History > 18 > period
2019-03-31
Earnings History > 18 > report Date
2019-05-02
Earnings History > 18 > date
2019-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.64
Earnings History > 18 > eps Estimate
-0.52
Earnings History > 18 > eps Difference
-0.12
Earnings History > 18 > surprise Percent
-23.0769
Earnings History > 19 > period
2018-12-31
Earnings History > 19 > report Date
2019-02-14
Earnings History > 19 > date
2018-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.49
Earnings History > 19 > eps Estimate
-0.58
Earnings History > 19 > eps Difference
0.09
Earnings History > 19 > surprise Percent
15.5172
Earnings History > 20 > period
2018-09-30
Earnings History > 20 > report Date
2018-11-01
Earnings History > 20 > date
2018-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.5
Earnings History > 20 > eps Estimate
-0.62
Earnings History > 20 > eps Difference
0.12
Earnings History > 20 > surprise Percent
19.3548
Earnings History > 21 > period
2018-06-30
Earnings History > 21 > report Date
2018-08-02
Earnings History > 21 > date
2018-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.85
Earnings History > 21 > eps Estimate
-0.35
Earnings History > 21 > eps Difference
-0.5
Earnings History > 21 > surprise Percent
-142.8571
Earnings History > 22 > period
2018-03-31
Earnings History > 22 > report Date
2018-05-31
Earnings History > 22 > date
2018-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-2.51
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2017-12-31
Earnings History > 23 > report Date
2018-02-28
Earnings History > 23 > date
2017-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
0
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2017-03-31
Earnings History > 24 > report Date
2017-05-04
Earnings History > 24 > date
2017-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.21
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.21
Earnings History > 24 > surprise Percent
-
Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AEliem Therapeutics (NASDAQ:ELYM) vs. Evelo Biosciences (NASDAQ:EVLO) Financial Survey Defense World
Read more βEVLO Completes Commissioning of First of Three Energy Storage Projects in American Samoa Newswire Canada
Read more βShowing 2 of 10
(Last Updated 2023-09-30)
Rating:
HOLD
Target Price:
$10
Analyst Picks
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2023-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low β€ 1
High β₯ 3
Return on Equity (ROE)
-
Very High
Low β€ 5%
High β₯ 25%
Return on Assets (ROA)
-
Very Low
Low β€ 2%
High β₯ 10%
* Institutions hold a combined 43.64% of the total shares of Evelo Biosciences Inc
1.
Flagship Ventures Management, Inc.(41.7884%)
since
2023/09/30
2.
Alyeska Investment Group, L.P.(1.3965%)
since
2023/09/30
3.
Acadian Asset Management LLC(0.2517%)
since
2023/12/31
4.
BlackRock Extended Mkt Composite(0.1331%)
since
2023/09/30
5.
XTX Topco Ltd(0.0537%)
since
2023/12/31
6.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.0145%)
since
2023/10/31
7.
GF NASDAQ Bio-Tech Idx QDII RMB A(0.0018%)
since
2023/12/31
8.
JHVIT Total Stock Market Index I(0.0007%)
since
2024/01/31
9.
Daiwa Securities Group Inc(0%)
since
2023/09/30
10.
Susquehanna International Group, LLP(0%)
since
2023/12/31
11.
Wells Fargo & Co(0%)
since
2023/12/31
12.
Tower Research Capital LLC(0%)
since
2023/12/31
13.
Northern Trust Corp(0%)
since
2023/12/31
14.
Barclays PLC(0%)
since
2023/12/31
15.
Millennium Management LLC(0%)
since
2023/12/31
16.
Harbourvest Partners, LLC(0%)
since
2023/12/31
17.
State Treasurer State Of Michigan(0%)
since
2023/12/31
18.
Morgan Stanley - Brokerage Accounts(0%)
since
2023/12/31
19.
Credit Suisse First Boston (CSFB)(0%)
since
2023/12/31
20.
Alphabet Inc(0%)
since
2023/12/31
21.
Advisor Group Holdings, Inc.(0%)
since
2023/09/30
22.
Royal Bank of Canada(0%)
since
2023/12/31
23.
FMR Inc(0%)
since
2023/12/31
24.
Citigroup Inc(0%)
since
2023/12/31
25.
China Universal NASDAQ Bio-Tch ETF(QDII)(0%)
since
2023/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
β
EPS Estimate
β
Date
2023-09-30
EPS Actual
-0.7112
EPS Estimate
-0.97
EPS Difference
0.2588
Surprise Percent
26.6804%
(Last Updated 2023-09-30)
(Last Updated 2023-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.